47P Phase I study to assess the safety and efficacy of P-BCMA-ALLO1: A fully allogeneic CAR-T therapy, in patients with relapsed/refractory multiple myeloma (RRMM)
| Autor: | Kocoglu, M.H., Asch, A., Ramakrishnan, A., Bachier, C., Martin, T., Rodriguez, T., McArthur, K., Martin, C., Namini, H., Ostertag, E., Spear, M., Christie, E., Belani, R., Zhang, M., Cranert, S., Coronella, J., Shedlock, D., Costello, C. |
|---|---|
| Zdroj: | In Immuno-Oncology and Technology December 2022 16 Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|